About Xerys
Xerys is a venture capital firm founded in 2009. It is primarily based out of Luxembourg, Luxembourg. As of Feb 2020, Xerys has invested in 10 companies. It primarily invests in Series B round in France based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and Retail. Most recently it participated in the $***** Series A round of Advanced BioDesign Overall, Xerys portfolio has seen 2 acquisitions, namely Seven Hugs and Datananas. A lot of funds co-invest with Xerys, with names like PARIS REGION Venture Fund sharing a substantial percentage of its portfolio. Xerys has team of 8 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio Acquisitions
Portfolio Soonicorns
Xerys' List of Top Investments
Xerys has a portfolio of 10 companies. Their most notable investments are in Herow and Herow.Their portfolio spans across France and United States. They have invested in Enterprise Applications, Life Sciences, Retail and 4 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by Xerys:1. Alzprotect
Alzprotect is focussed on the development of drugs for neurodegenerative diseases. Its lead candidate AZP2006 is a small molecule which is based on the macroautophagy and modulates the degradation of both APP and Tau protein fragments and thus detoxifies the neurons. The candidate is currently in phase 2 trials for Progressive Supranuclear Palsy (PSP) and in phase 1 studies for Alzheimer's.
Key facts about Alzprotect
2. Seven Hugs
Seven Hugs develop home automation solutions. It provides a remote control device that enables users to monitor/control TV, music, and lights for residential purposes. It leverages display, touch, voice and contextual awareness via AI technology.
Key facts about Seven Hugs
- Founded Year: 2013
- Location: San Francisco (United States)
- Stage: Acquired
- Total Funding till date: $25.8M
- Employee Count: 5 as on Sep 30, 2026
- Investors: Kima Ventures, SaaS Lander and 9 Others
- Latest Funding Round: Series A, Dec 11, 2019, $*****
- Highlight: Acquired
3. Biolog-id
Developer of traceability solutions for health products. The products include labile blood products (packed red blood cells, platelets, therapeutic plasma), plasma for fractionation, and chemotherapy injectables.
Key facts about Biolog-id
- Founded Year: 2005
- Location: Bernay (France)
- Stage: Series B
- Total Funding till date: $33.2M
- Employee Count: 67 as on Aug 31, 2026
- Investors: Altamira Capital Partners and Xerys
- Latest Funding Round: Series B, Nov 20, 2019, $*****
- Highlight: Editors' Pick
4. Herow
Herow is a customer engagement and marketing platform. It provides a marketing platform that allows analyzing customers, segments them with behaviors and engages with relevant campaigns. It lets to understand customer traffic, visualize geographically where a customer goes, where they use the app and where they don't. It also notifies when the customer is in a specific location or context.
Key facts about Herow
- Founded Year: 2007
- Location: Paris (France)
- Stage: Series B
- Total Funding till date: $18.6M
- Employee Count: 2 as on Aug 31, 2026
- Investors: XAnge, Calao Finance and 4 Others
- Latest Funding Round: Series B, Oct 15, 2019, $*****
- Highlight: Editors' Pick
Advanced Biodesign is an Immuno- technology company. There are several services the company offers using immuno-technology namely Antibody discovery, bioanalytics and bioassay development, and biosimilars. Apart from this, the company has developed an assay to track apoptosis using Apocell, an apoptosis marker. It is also developing Sefaldin (Dimate), an aldehyde dehydrogenase inhibitor (preclinical) for the treatment of a wide range of cancers including AML, NSC Lung Cancer, Breast Cancer, Melanoma, Osteosarcoma, Pancreas Cancer, and Colorectal Cancer.
Key facts about Advanced BioDesign
Xerys' Year-on-Year Investment Trends
Xerys has invested in 10 companies over the last 13 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Advanced BioDesign and most recent follow-on round was in Seven Hugs.Xerys' Investments by Stage
Xerys has made 4 investments in Series A stage with an average round size of $10.4M, 3 investments in Seed stage with an average round size of $1.61M and 2 investments in Series B stage with an average round size of $13.9M.Stage of entry | No. of Investments |
|---|---|
Series A | 4 |
Seed | 3 |
Series B | 2 |
Note: We have considered here, only first round of investments
Xerys' Investments by Sector
Xerys has a diverse portfolio, with companies operating in the Enterprise Applications, Environment, Life Sciences, Energy and HealthTech. Notably, it has invested in 7 Tech companies, 6 Enterprise (B2B) companies, 5 Software companies and at least 2 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 4 |
Environment | 2 |
Life Sciences | 2 |
Energy | 1 |
HealthTech | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Xerys' Investments by Geography
Xerys has made most investments in France (8), followed by United States where it has made 1 investment.Country | No. of Investments |
|---|---|
France | 8 |
United States | 1 |
Note: We have considered here, only first round of investments
Xerys' recent investments
Xerys has not made any investment in 2026 so far.Here are the most recent investments by Xerys:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 25, 2020 | France | Series A | 8182 | - | |
Dec 11, 2019 | United States | Series A | 1770 | - | |
Nov 20, 2019 | France | Series B | 9509 | - | |
Oct 15, 2019 | France | Series B | 8595 | [+1] | |
Feb 26, 2018 | France | Seed | 7972 | [+1] |
Acquired companies in Xerys' Portfolio
2 companies from Xerys' portfolio have been acquired. The most recent acquisition was Seven Hugs in Nov 2020 by Qorvo for $*****.Here are Xerys' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 05, 2020 | Jun 22, 2016 | Series A | 1674 | |
Apr 01, 2020 | Feb 26, 2018 | Seed | 3348 |
Team profile of Xerys
Xerys has a team of 8 members including 3 Partners and 3 Principals located in France and Switzerland. Xerys' team does not sit on the board of any company as of now.Here is a list of all team members in Xerys:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Paris | - | - | |
Partner | Lausanne | - | ||
Partner | France | - | - | |
Principal | Paris | - | - | |
Principal | France | - | ||
Principal | Paris | - |
Co-investors of Xerys
Over the past 13 years, 17 investors have co-invested in Xerys's portfolio companies. This includes funds and angels.
- Invested before Xerys: Finovam Gestion, Siparex and 8 others have invested in rounds before Xerys. There is 1 company where Finovam Gestion has invested before Xerys and 1 company where Siparex has invested before Xerys.
- Top Co-investors of Xerys: 5 investors entered a company along with Xerys. These include investors like PARIS REGION Venture Fund (1 company).
- Invested after Xerys: Europa (1 company) and Bouygues Dveloppement (1 company) are the investors which have invested in Xerys's portfolio after their investments.
Recent News related to Xerys
•
•
Leader in Innovative Smart Home Solutions, Sevenhugs, Has Raised an Additional $9 Million From Xerys CapitalePRNews•Dec 11, 2019•Seven Hugs, Xerys, Frci-idf.com, CapDecisif Management and 1 other
•
Biolog-id Raises 30 Million Euros From Funds Managed by XerysBusiness Wire•Nov 19, 2019•Biolog-id, Xerys
•
Herow Raises $18.6M in Series B FundingFinSMEs•Oct 15, 2019•Herow, Calao Finance, Xerys, Siparex and 1 other
•
Datananas Raises €1M in FundingFinSMEs•Feb 26, 2018•Datananas, Xerys, Bernard Kirsch, Bernard Kirsch
•
AlzProtect raises €14 million with the entry of Xerys as lead investorAngel News•Jan 22, 2018•Alzprotect, Xerys
